Toward the top of the list is PTEN, an inhibitor of the PI3K/Akt pathway that we have previously shown to be important in regulating IPF fibroblast proliferation and survival (28–30). The gene discussed is AKT1; the disease is idiopathic pulmonary fibrosis.